Excluded were patients with a history of drug or alcohol abuse, impaired renal function with serum creatinine ≥1.7 mg/dL, cardiac disease (defined as decompensated heart failure, unstable angina pectoris, myocardial infarction within the last 12 months, or severe uncontrolled hypertension ), proliferative retinopathy and/or advanced neuropathy as judged by the investigator, experience and education using the OTDMS system twice or more, as well as those who were treated with any other drug known to affect blood glucose (i.e., monoamine oxidase inhibitors, β-adrenergic agents, anabolic steroids, and systemic glucocorticoids), were pregnant or breast-feeding, and had the intention to become pregnant. Patients who fulfilled the following criteria were included in the study: (1) the diagnosis of T2DM according to World Health Organization classification, (2) current treatment with oral hypoglycemic agent(s) for at least 3 months, and (3) willingness and ability to perform SMBG using OneTouch Ultra. This study was conducted in a single center for diabetes education in Korea from August 2009 to October 2010. The purpose of this study was to evaluate whether the use of OTDMS would improve patients' (1) knowledge of diabetes mellitus (DM), (2) compliance, (3) satisfaction with doctor and medical treatment, (4) doctor-patient reliability, and (5) glucose control. It shows all data of blood glucose level with marks of "low," "under control," and "high." It also shows daily variation of blood glucose level with line graph and proportion of "low," "under control," and "high" blood glucose level with a pie chart, as well as the distribution of blood glucose level and the proportion of "low," "under control," and "high" blood glucose level according to time variation.
OneTouch Ultra, via the meter's data port, which connects to a glucometer and computer, makes it possible to download data from a point-of-care testing device and transform the numbers of the blood glucose level into a graph, a chart, or statistics.
OneTouch Diabetes Management Software (OTDMS) is designed to track and monitor the blood glucose level. Data collection tools such as structured SMBG could help physicians. Collecting blood glucose level and showing it as a time-based graph would help doctors to see blood glucose control intuitionally. įor appropriate SMBG, physicians can correctly identify glycemic abnormalities in SMBG data obtained through structured, episodic SMBG. A systematic review showed three types of recording error in patient diaries, which incorrectly recorded a value that had been measured (lack of concordance), failed to record a value that had been measured (under-reporting), and added a value to the diary that had not been measured (over-reporting). However, patient-generated SMBG diary records are known to have more recording error compared with meter memory.
SMBG has become a component of effective therapy. reported that appropriate and structured SMBG significantly improved glycemic control and facilitated more timely/aggressive treatment changes in noninsulin-treated type 2 diabetes mellitus (T2DM), without decreasing general well-being. The results of SMBG are valuable and useful for treatment only when it is collected well and analyzed exactly. SMBG reflects the adequacy of treatment, promotes healthy behavior, and improves clinical course. To assess the effectiveness of the management plan in glycemic control, patient self-monitoring of blood glucose (SMBG) and glycosylated hemoglobin (HbA1c) have been applied.